Dual Agonists for Management of Metabolic Dysfunction–Associated Steatohepatitis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Dual Agonists for Management of Metabolic Dysfunction–Associated Steatohepatitis

Published:2024-07-25 Issue:4 Volume:391 Page:371-372
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Kanwal Fasiha¹

Affiliation:

1. From the Section of Gastroenterology and Hepatology, Department of Medicine, Baylor College of Medicine, the Veterans Affairs Health Systems Research Center for Innovations in Quality, Effectiveness, and Safety, and the Michael E. DeBakey Veterans Affairs Medical Center — all in Houston.

Publisher

Massachusetts Medical Society

Link

http://www.nejm.org/doi/pdf/10.1056/NEJMe2406487

Reference13 articles.

1. The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis

2. Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials

3. A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis

4. Semaglutide 2·4 mg once weekly in patients with non-alcoholic steatohepatitis-related cirrhosis: a randomised, placebo-controlled phase 2 trial

5. Tirzepatide for Metabolic Dysfunction–Associated Steatohepatitis with Liver Fibrosis

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP